Hematology Disease Center
Hematologic cancers include lymphomas and leukemias, which affect the lymph nodes and bone marrow, respectively. Together, members of the Hematological Malignancies and Hematology Center research to better understand how to prevent and treat these cancers. The goals include:
- Identify new therapeutic targets to guide the future of treatment
- Develop new treatments for hematologic malignancies
- Identify inherited factors that increase the risk for hematologic malignancies
- Conduct clinical trials to expand the treatment portfolio for patients
Hematology Disease Center Leader
Douglas W. Sborov, MD, MS
Hematology Disease Center Leadership Council
- Philanthropy: Douglas Sborov, Boyu Hu, Srinivas Tantravahi
- Pilot Awards: Anna Beaudin
- Biobank: Shannon Buckley
- Correlative Science: Tony Pomicter
- Statistics: Yizhe Xu
- Community Outreach and Education: Alli Bock
- Drug Development: Paul Shami, Ramiro Garzon
- Outreach and Communications: Harsh Shah
- Clinical Trial Innovation: Naren Epperla
- Staff Research (APC,RN): Mary Steinbach
- Pediatrics: Birgit Knoechel
- Scientific Advancement: Jens Lohr
- ADAPT Program Liaison: Sagar Patel
- Trainee Engagement: Gliceida Galarza Fortuna
- Clinical Advancement: Brian McClune
Events and Media
Huntsman SportsFest
Join the movement—literally—at Huntsman SportsFest, where running, riding, and walking raise funds for cutting-edge research and cancer treatments.
- Activities: Ride, run, walk, or play
- Register solo or as a team
- Funds raised support cancer research, with optional designation by cancer type
Hematology CONNECTIONS Newsletter
Our annual newsletter provides updates on research, events, and hematology news.